Novamont, Turin Polytechnic and University of Bologna launched in Rome, ReSoil Foundation, a new tool to boost a real change, starting from soil health and the key concept of territorial regeneration.
The new foundation aims at promoting activities in the fields of scientific research, technology transfer, training and dissemination, and the creation of awareness on issues related to soil health, a non-renewable resource, increasingly degraded by the anthropogenic action, pollution and climate change.
Last Wednesday Theresa May announced a statutory instrument to amend the UK Climate Change Act of 2008. The law currently prescribes an emissions cut of 80% by 2050, from a 1990 baseline. The new law will aim for net zero emissions by 2050, making the U.K. the first G7 nation to pass such legislation.
In the same day, against a backdrop of growing global awareness of the importance of environmentalprotection, the Embassy of Italy in London launched“Zero-Waste Embassy”, aiming toreduce significantly the environmental impact of the mission’s energy supply, waste management and consumption.
The initiative falls under the umbrella of Farnesina Verde(Green Foreign Ministry), a plan for the Italian diplomatic network worldwide, overseen by the Italian Ministry of Foreign Affairs. Continue reading →
The final event of the European project FIRST2RUN will take place at the Square Convention centre in Brussels on June 20. Co-ordinated by Italian biochemical company Novamont and funded by the Bio-Based Industries Joint Undertaking under the European Union’s Horizon 2020 research and innovation programme, FIRST2RUN is a flagship project involving four companies and universities from Italy, UK and The Netherlands.
Mater Bipolymer, a 100% company owned by Novamont, today celebrates its Grand Opening in Patrica (Frosinone, Central Italy). The plant represents a new important element of Novamont’s bioeconomy model. “Another virtuous example of territorial regeneration of industrial infrastructures that are no longer competitive”, the company headquartered in Novara claims.
Genomatica has strong results for its GENO BDO biobased process technology regarding overall process performance and production volume to date for bio-based 1,4-butanediol (BDO). Novamont, Genomatica’s first GENO BDO licensee, has officially confirmed that its new industrial plant in Bottrighe, Italy has met all performance guarantees committed to by Genomatica. The guarantees include technical and economic parameters, such as efficiency of converting feedstock sugars to Bio- BDO product and product quality. The process runs as designed, as modeled, and as represented.
The Giro, one of three three-week Grand Tours that include the Tour de France and Vuelta a España, goes green. After the success of the first edition in 2016, the Ride Green project will once again accompany this year’s Giro d’Italia, the competition which for 100 years has showcased sporting competitiveness, the passion of the race fans and the beauty of Italy.
Novamont has exercised its option to acquire the remaining 22% of the share capital of Mater-Biopolymer srl. The Bioplastics firm headquartered in Novara, Northern Italy, acquired in 2014 a majority stake (78%) in the company that operates a resin plant in Lazio, Central Italy, and was a unit of PET resin maker Gruppo Mossi Ghisolfi.
Yesterday in Milan, Italy, started the first edition of the first European Master in Bioeconomy in the Circular economy. To organise it are four Italian universities from North to South (University of Turin, University of Milan Bicocca, University of Bologna and University of Naples Federico II), with the support of three of the main Italian bioeconomy players (Novamont, GFBiochemicals and Science Park of Lodi) and the Italian leading banking Group Intesa Sanpaolo, which is the only financial global partner of the Ellen McArthur Foudation.
“Biotech is becoming increasingly important to the mainstream chemical industry as the demand for more sustainable solutions intensifies. Biotech is especially well-suited to help with some of the industry’s biggest challenges”. To say it – in this exclusive interview with Il Bioeconomista – is Christophe Schilling, founder and CEO of Genomatica, a widely-recognized bioengineering leader for the chemical industry. The San Diego-based biotechnology company develops and licenses bio-based manufacturing processes for the production of intermediate and basic chemicals.
Since being named CEO in May 2009, Christophe Schilling has led Genomatica to widespread recognition as a leader in industrial biotechnology, with a commercialized first process, top-tier licensees, strong investors and an unrivaled string of awards for engineering (Kirkpatrick), science (EPA Presidential Green Chemistry), industry leadership (voted #1 Hottest three years in a row by Biofuels Digest), and company culture (The Scientist as a Best Place to Work). Schilling frequently speaks on industry trends at major conferences and serves as a member of the World Economic Forum Global Agenda Council on Biotechnology.